Advertisement
Screener

AirSculpt Technologies, Inc. (AIRS) ROI

Airsculpt Technologies, Inc. ROI

Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Airsculpt Technologies, Inc. roi for the quarter ending 2026-06-30 was -7.91%, a change of 1.75% year-over-year.
  • Airsculpt Technologies, Inc. roi for the quarter ending 2026-03-31 was -7.73%, a change of 3.94% year-over-year.
  • Airsculpt Technologies, Inc. roi for the quarter ending 2025-12-31 was -8.12%, a change of -2.69% year-over-year.
  • Airsculpt Technologies, Inc. roi for the quarter ending 2025-09-30 was -12.77%, a change of -7.82% year-over-year.
  • Airsculpt Technologies, Inc. roi for fiscal 2025 was -8.12%, a change of -2.69% from fiscal 2024.
  • Airsculpt Technologies, Inc. roi for fiscal 2024 was -5.42%, a change of -2.67% from fiscal 2023.
  • Airsculpt Technologies, Inc. roi for fiscal 2023 was -2.75%, a change of 6.76% from fiscal 2022.
  • Airsculpt Technologies, Inc. roi for fiscal 2022 was -9.51%, a 249.78% decline from fiscal 2021.
Available history
2021-12-31 to 2026-06-30
Data captured

Historical ROI

DateROINet income 12 monthNet income 3 monthDebt plus equity
2026-06-30-7.91%-$11.74M-$1.11M$148.4M
2026-03-31-7.73%-$11.22M-$2.40M$145.08M
2025-12-31-8.12%-$11.67M$1.28M$143.76M
2025-09-30-12.77%-$17.75M-$9.51M$139.02M
2025-06-30-9.66%-$14.28M-$591.00K$147.79M
2025-03-31-11.67%-$16.89M-$2.85M$144.74M
2024-12-31-5.42%-$8.02M-$4.80M$147.89M
2024-09-30-4.95%-$7.55M-$6.04M$152.68M
2024-06-30-2.04%-$3.18M-$3.21M$155.74M
2024-03-311.17%$1.8M$6.03M$154.68M
2023-12-31-2.75%-$4.24M-$4.33M$154.29M
2023-09-30-4.52%-$7.1M-$1.67M$156.92M
2023-06-30-7.79%-$12.81M$1.78M$164.47M
2023-03-31-8.83%-$14M-$14.00K$158.5M
2022-12-31-9.51%-$14.68M-$7.19M$154.31M
2022-09-30-5.09%-$7.88M-$7.38M$154.92M
2022-06-304.19%$7.55M$583.00K$180.1M
2022-03-319.85%$17M-$693.00K$172.47M
2021-12-3114.63%$24.31M-$14.15M$166.13M

Annual ROI

DateROINet income 12 monthDebt plus equity
2025-12-31-8.12%-$11.67M$143.76M
2024-12-31-5.42%-$8.02M$147.89M
2023-12-31-2.75%-$4.24M$154.29M
2022-12-31-9.51%-$14.68M$154.31M
2021-12-316.35%$10.55M$166.13M

Similar stocks

Stock NameCountryMarket CapPE Ratio
LifeMD, Inc. (LFMD)United States$0.141B982.53
SBC Medical Group Holdings Inc (SBC)United States$0.487B
Teladoc Health, Inc. (TDOC)United States$1.114B-8.68